Diseases of the Cardiovascular System, Phase II-III

DAL-302

Volunteers
Health Professionals

What is the purpose of this trial?

The dal-GenE-2 clinical research study is testing an investigational medication to treat Acute Coronary Syndrome (ACS) in those who have the target gene variant. The DAL-302 study evaluates the effect of dalcetrapib (Study drug) on the risk of having a major cardiovascular event, including death, heart attack, and stroke.

Ages
45 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact David Kingsbury, BSN RN

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Antonio Giaimo, MD
Assistant Professor of Cardiovascular Medicine

Sub-Investigators

Last Updated
11/25/2025
Study HIC
#2000039690